Catalyst Pharm Inc (CPRX)

$23.23 -0.16 (-0.68%)
Market Cap 2.84B
Revenue (ttm) 588.99M
Net Income (ttm) 214.33M
EPS (ttm) N/A
PE Ratio 9.18
Forward PE 8.67
Profit Margin 36.39%
Debt to Equity Ratio 0.00
Volume 1,024,000
Avg Vol 1,251,162
Day's Range N/A - N/A
Shares Out 122.12M
Stochastic %K 15%
Beta 0.75
Analysts Strong Sell
Price Target $34.86

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 420 3200
Address:
355 Alhambra Circle, Suite 801, Coral Gables, United States
Starrider111
Starrider111 Mar. 13 at 2:32 PM
I bought $CPRX & $WY today
0 · Reply
StillWaiting101
StillWaiting101 Mar. 13 at 2:05 PM
$CPRX seems like a perfect time for me to start buying
1 · Reply
111ggg
111ggg Mar. 13 at 1:51 PM
$CPRX within 30 days we should know which direction she goes.
0 · Reply
BlackSwan13
BlackSwan13 Mar. 12 at 10:19 PM
$CPRX Judge Michael E. Farbiarz of the U.S. District Court for the District of New Jersey, do the right thing!!
0 · Reply
Cooco
Cooco Mar. 12 at 7:04 PM
$CPRX sad that im stuck
1 · Reply
BoltTrade
BoltTrade Mar. 11 at 6:07 PM
$SXTP has gone up 55% and still only 2,391 people are watching this stock. Clinical results came in, and all 3 patients were CURED! Let’s talk about 🚀🚀🚀 $VRTX $BNTX $MRNA $CPRX
0 · Reply
StillWaiting101
StillWaiting101 Mar. 11 at 4:02 PM
$CPRX give me under $24 again, I don't mind another chance to swing $23.xx to $25
2 · Reply
Doozio
Doozio Mar. 11 at 4:56 AM
$CPRX 3/2 MNDY 🐑 appears obvious ENTA 🐒🍌🧠⏰♾️.
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 8 at 4:28 PM
$CPRX Catalyst Pharmaceuticals (NASDAQ: CPRX) just posted record revenue and strong growth driven by blockbuster therapies like FIRDAPSE and AGAMREE. With biotech investors hunting for undervalued opportunities, CPRX is gaining attention as a cheap biotech stock showing strong fundamentals and expanding market demand. https://biotechhealthx.com/biotech-news/is-it-a-wise-move-to-acquire-catalyst-pharmaceuticals-cprx-shares/
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 6 at 5:40 PM
$AUPH $BMRN $CPRX $HALO $HRMY Biotech stocks may be starting slow this year, but analysts believe the sector could be setting up for a powerful comeback. With massive pharmaceutical patent expirations approaching and over $1 trillion in industry capital ready for deals, these cheap biotech stocks could offer significant upside for investors searching for undervalued healthcare opportunities. https://biotechhealthx.com/biotech-news/10-cheap-biotech-stocks-to-buy-now/
0 · Reply
Latest News on CPRX
Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 10, 2026, 5:40 PM EDT - 5 days ago

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

Mar 6, 2026, 8:03 AM EST - 9 days ago

Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 3:27 PM EST - 17 days ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Feb 25, 2026, 4:07 PM EST - 18 days ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference

Feb 24, 2026, 8:03 AM EST - 19 days ago

Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference

Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs

Feb 19, 2026, 11:39 AM EST - 24 days ago

Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Feb 11, 2026, 8:03 AM EST - 4 weeks ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 9:25 PM EST - 2 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Jan 8, 2026, 8:03 AM EST - 2 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 8:03 AM EST - 3 months ago

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript

Dec 8, 2025, 4:07 PM EST - 3 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 4:43 PM EST - 3 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Nov 24, 2025, 8:03 AM EST - 3 months ago

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™

Nov 19, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™

Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

Nov 18, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 8:36 PM EST - 4 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2025 Earnings Call Transcript

Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 5, 2025, 4:06 PM EST - 4 months ago

Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

Nov 4, 2025, 4:03 PM EST - 4 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Nov 3, 2025, 8:03 AM EST - 4 months ago

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 22, 2025, 8:03 AM EDT - 5 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025

Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

Oct 9, 2025, 8:03 AM EDT - 5 months ago

Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program

Oct 1, 2025, 8:03 AM EDT - 5 months ago

Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 28, 2025, 8:03 AM EDT - 7 months ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 26, 2025, 7:12 PM EDT - 7 months ago

UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 25, 2025, 8:03 AM EDT - 7 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 2:21 PM EDT - 7 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call Transcript

Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Aug 6, 2025, 4:13 PM EDT - 7 months ago

Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)

Aug 6, 2025, 8:03 AM EDT - 7 months ago

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)

Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors

Aug 4, 2025, 8:03 AM EDT - 7 months ago

Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors

Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 22, 2025, 8:03 AM EDT - 8 months ago

Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:08 AM EDT - 9 months ago

Strong Inflows Make Catalyst Stock an Outlier

20 stocks you should avoid — no matter how well the market does

Jun 11, 2025, 7:00 AM EDT - 9 months ago

20 stocks you should avoid — no matter how well the market does

CORT CRK CRNC DDD LUMN LYV MGPI

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

Jun 2, 2025, 8:03 AM EDT - 10 months ago

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma

May 31, 2025, 5:18 AM EDT - 10 months ago

Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call Transcript

May 8, 2025, 12:02 PM EDT - 11 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call Transcript

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

May 7, 2025, 4:14 PM EDT - 11 months ago

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Apr 30, 2025, 8:03 AM EDT - 11 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 22, 2025, 8:03 AM EDT - 11 months ago

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

Apr 8, 2025, 8:06 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 26, 2025, 8:12 AM EDT - 1 year ago

Strong Revenue, Drug Performance Lift Catalyst Shares

Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts

Mar 11, 2025, 4:05 AM EDT - 1 year ago

Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Mar 4, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges

Mar 3, 2025, 2:39 PM EST - 1 year ago

Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 12:29 PM EST - 1 year ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 26, 2025, 4:13 PM EST - 1 year ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Feb 12, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Catalyst Remains a Big Money Favorite

Feb 7, 2025, 3:56 PM EST - 1 year ago

Catalyst Remains a Big Money Favorite

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Jan 23, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

Jan 21, 2025, 8:19 AM EST - 1 year ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE

Jan 13, 2025, 8:30 AM EST - 1 year ago

Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE

Starrider111
Starrider111 Mar. 13 at 2:32 PM
I bought $CPRX & $WY today
0 · Reply
StillWaiting101
StillWaiting101 Mar. 13 at 2:05 PM
$CPRX seems like a perfect time for me to start buying
1 · Reply
111ggg
111ggg Mar. 13 at 1:51 PM
$CPRX within 30 days we should know which direction she goes.
0 · Reply
BlackSwan13
BlackSwan13 Mar. 12 at 10:19 PM
$CPRX Judge Michael E. Farbiarz of the U.S. District Court for the District of New Jersey, do the right thing!!
0 · Reply
Cooco
Cooco Mar. 12 at 7:04 PM
$CPRX sad that im stuck
1 · Reply
BoltTrade
BoltTrade Mar. 11 at 6:07 PM
$SXTP has gone up 55% and still only 2,391 people are watching this stock. Clinical results came in, and all 3 patients were CURED! Let’s talk about 🚀🚀🚀 $VRTX $BNTX $MRNA $CPRX
0 · Reply
StillWaiting101
StillWaiting101 Mar. 11 at 4:02 PM
$CPRX give me under $24 again, I don't mind another chance to swing $23.xx to $25
2 · Reply
Doozio
Doozio Mar. 11 at 4:56 AM
$CPRX 3/2 MNDY 🐑 appears obvious ENTA 🐒🍌🧠⏰♾️.
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 8 at 4:28 PM
$CPRX Catalyst Pharmaceuticals (NASDAQ: CPRX) just posted record revenue and strong growth driven by blockbuster therapies like FIRDAPSE and AGAMREE. With biotech investors hunting for undervalued opportunities, CPRX is gaining attention as a cheap biotech stock showing strong fundamentals and expanding market demand. https://biotechhealthx.com/biotech-news/is-it-a-wise-move-to-acquire-catalyst-pharmaceuticals-cprx-shares/
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 6 at 5:40 PM
$AUPH $BMRN $CPRX $HALO $HRMY Biotech stocks may be starting slow this year, but analysts believe the sector could be setting up for a powerful comeback. With massive pharmaceutical patent expirations approaching and over $1 trillion in industry capital ready for deals, these cheap biotech stocks could offer significant upside for investors searching for undervalued healthcare opportunities. https://biotechhealthx.com/biotech-news/10-cheap-biotech-stocks-to-buy-now/
0 · Reply
StockNews_Live
StockNews_Live Mar. 6 at 1:03 PM
$CPRX Catalyst Pharmaceuticals, Inc. will showcase real-world findings in Duchenne muscular dystrophy (DMD) through multiple poster presentations at the 2026 MDA Clinical & Scientific Conference in Orlando,…
0 · Reply
111ggg
111ggg Mar. 5 at 4:46 PM
$CPRX that 25 is a rock solid top until lawsuit is settled. Then it might see 30 or break 20 depending on decision.
3 · Reply
erevnon
erevnon Mar. 3 at 7:16 PM
Citigroup maintains Catalyst Pharmaceuticals $CPRX at Buy and raises the price target from $33 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
dnsfw
dnsfw Mar. 3 at 4:14 AM
$CPRX https://clarval.com/?ticker=CPRX
0 · Reply
WB_Bull
WB_Bull Mar. 2 at 9:08 PM
$CPRX what happened? 1,4 mio shares in 1 hour ! are there news around the corner? good luck
1 · Reply
sunset_PARK
sunset_PARK Mar. 2 at 8:52 PM
$CPRX $KNSA $TARS they all moved last 30mins withvolume, similar market cap in bio, any news, any others? Seems not in the same index?
1 · Reply
StillWaiting101
StillWaiting101 Mar. 2 at 8:46 PM
$CPRX nice colume on that big green candle too, they took it down to low $22 range today just to clear out some retail, then they pile in, luckily we have seen this all before and long time retail holders probably didn't even flinch this morning
1 · Reply
StillWaiting101
StillWaiting101 Mar. 2 at 8:37 PM
$CPRX look at that candle, nice
0 · Reply
toradio
toradio Mar. 2 at 4:25 PM
$CPRX wait...do i see "red to green"?? nice...lol...
0 · Reply
StillWaiting101
StillWaiting101 Feb. 27 at 8:42 PM
$CPRX suppose I could have been even more patient, will just add some as far down as they want to take it, like I always do on these dips, not my first rodeo
2 · Reply
TheAlphaTrade
TheAlphaTrade Feb. 27 at 7:49 PM
$CPRX 🤔 $29 with some time
0 · Reply
StillWaiting101
StillWaiting101 Feb. 27 at 5:14 PM
$CPRX weird move, but I will buy a few here
1 · Reply